Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Jingle Ju
Columbia Univ New York Morningside, Department: Engineering (All Types)
Should you be removed from our database? Contact us at [email protected]. Read more below.
Roche (formerly Genia)
Other : Intellectual property-related payments received through the institution
Dr. Ju is entitled to receive an inventor's share of license fees and royalties through a license from Columbia University to Roche (formerly Genia). Columbia's Policy on Financial Conflicts of Interest and Research includes royalties above $5,000, even if received through the University, in its definition of "significant financial interest." Dr. Ju has received royalty payments from Roche over the past 12 months not exceeding $5,000. However, Dr. Ju received payments well above $5,000 in 2014, while working on the first-year increment of this grant, that are being reported here for the first time.
In 2014, Roche acquired Genia and the acquisition triggered a one-time payment to Columbia pursuant to the terms of the license agreement with Genia (the "change of control payment"). Dr. Ju was entitled to an inventor's share of this payment, and in 2014 he received payments from Roche/Genia (through Columbia) on the order of (b)(4). In 2015, Dr. Ju's payments from Roche/Genia did not exceed $5,000. It is unknown whether he will receive payments in 2016 exceeding (b)(4).
Dr. Ju continues to conduct research related to the licensed technology. In addition, Roche/Genia is a collaborator on this award. In light of these facts, Columbia has determined that the outcome of this research could affect the company and Dr. Ju's royalty interest in Roche/Genia, and that the design, conduct, and/or reporting of the research could be affected by this financial interest. The FCOI Committee found the risk resulting from the FCOI to be mitigated by the fact that the ultimate product of the research -- the electronic sequencing platform -- will be validated independently, but still determined there to be an FCOI that warrants management.
An Integrated System for Single Molecule Electronic Sequencing by Synthesis
There is a great need to reduce the cost of DNA sequencing to achieve the goal of the $1000 genome. The proposed Nano-SBS system will lay the foundation for the production of a commercial single molecule electronic DNA sequencing platform, which will enable routine use of sequencing for medical diagnostics and personalized medicine. (NOTE: The three headings listed above must be included in the document that is submitted even if a particular section had no changes from the previous submission. If there are no changes for a section include the header but leave the text area blank to ensure appropriate processing of this information by NIH's electronic systems. ) 3
Filed on December 15, 2016.
Tell us what you know about Jingle Ju's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.